Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia.
These guidelines on the management of HSV, VZV and EBV infection in patients with hematological malignancies and after SCT were prepared by the European Conference on Infections in Leukemia following a predefined methodology. A PubMed search was conducted using the appropriate key words to identify studies pertinent to management of HSV, VZV and EBV infections. References of relevant articles and abstracts from recent hematology and SCT scientific meetings were also reviewed. Prospective and retrospective studies identified from the data sources were evaluated, and all data deemed relevant were included in this analysis. The clinical and scientific background was described and discussed, and the quality of evidence and level of recommendation were graded according to the Centers for Disease Control criteria.
Styczynski
J
J
Department of Pediatric Hematology and Oncology, Collegium Medicum UMK, Bydgoszcz, Poland.
Reusser
P
P
Einsele
H
H
de la Camara
R
R
Cordonnier
C
C
Ward
K N
KN
Ljungman
P
P
Engelhard
D
D
D019468:Disease Management; D020031:Epstein-Barr Virus Infections / Q000175:diagnosis / Q000188:drug therapy; D019337:Hematologic Neoplasms / Q000150:complications* / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006561:Herpes Simplex / Q000175:diagnosis / Q000188:drug therapy; D006562:Herpes Zoster / Q000175:diagnosis / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D006801:Humans